• DEEPBLUE Coronavirus (COVID-19) antigen detection reagent-saliva has passed CE1434 certification, and its comprehensive strength has been internationally recognized

    Company News Nov 19, 2021

    DEEPBLUE Coronavirus (COVID-19) antigen detection reagent-saliva has passed CE1434 certification, and its comprehensive strength has been internationally recognized
    Anhui Deepblue Medical Technology Co., Ltd. (hereinafter referred to as "Deepblue Medical") has made great achievements in expanding the market recently. Its domestic business is booming, and its foreign trade business is constantly breaking through. In order to better serve the EU market, Deepblue Medical has been deeply engaged in the field of technology research and development. After unremitting efforts, the self-developed novel coronavirus (COVID-19) antigen detection reagent-saliva has successfully obtained the CE1434 certificate on November 10, 2021. Deepblue medical novel coronavirus (COVID-19) antigen detection reagent-saliva successfully obtained the CE1434 certificate. So far, Deepblue Medical has passed CE1434 certification for 3 types of novel coronavirus (COVID-19) products, mainly including novel coronavirus (COVID-19) neutralizing antibody (double antigen sandwich) detection reagents, novel coronavirus (COVID-19) antigen detection reagents -Anterior nose, novel coronavirus (COVID-19) antigen detection reagents-saliva, so far, Deepblue Medical is one of the only IVD companies in China that have obtained three certificates at the same time. Deepblue Medical has a wealth of novel coronavirus products and detection solutions. Help global epidemic prevention and control. Deepblue Medical Novel Coronavirus (COVID-19) Antigen Saliva Detection Reagent can quickly detect whether saliva contains nocel coronavirus through saliva samples collected from individuals. It is a very suitable product for personal and family self-testing. It has the following main features Features: Convenient sampling Convenient and fast The results are accurate Since the early stage of the outbreak of the novel coronavirus, Deepblue Medical has integrated its technical strength, and its self-developed series of novel coronavirus (COVID-19) antigen detection reagents have been verified by multiple authoritative institutions: through the British Phase 3B test, the German BfarM special authorization, the Netherlands MINVWS special authorization, etc. The CE1434 certification of the series of novel coronavirus products not only reflects that the product's excellent performance and good user experience have been fully recognized, and meets the needs of the international market, it is also a favorable evidence for Deepblue Medical's influence in the IVD industry, international customer recognition, and international competitiveness. . Deepblue Medical Novel Coronavirus (COVID-19) Antigen Detection Reagent - Saliva Detection Reagent Relying on professional scientific research and innovation strength, Deepblue Medical has independently developed novel coronavirus (COVID-19) antigen saliva detection reagents in a faster and more convenient way to meet the needs of individuals and families for self-testing, allowing more people to cut the infection chain faster , to prevent the risk of virus transmission. In addition, Deep Blue can also provide a full range of rapid detecti...
    View More
  • DEEPBLUE Novel Coronavirus (COVID-19) Neutralizing Antibody (Double Antigen Sandwich) Detection Reagent was awarded CE 1434 Certificate

    Company News Oct 11, 2021

    DEEPBLUE Novel Coronavirus (COVID-19) Neutralizing Antibody (Double Antigen Sandwich) Detection Reagent was awarded CE 1434 Certificate
    On October 8, 2021, the novel coronavirus (COVID-19) neutralizing antibody (double antigen sandwich) detection reagent (colloidal gold method) independently developed by Anhui Deepblue Medical successfully obtained the CE1434 certificate, which meets the relevant EU requirements and market standards. Entry qualification. CE 1434 self-test certification is not only difficult, long-term, and strict, but also a test of comprehensive strength. In July 2021, DeepBlue Medical's novel coronavirus (COVID-19) antigen detection reagent obtained the CE1434 certificate, and the new coronavirus (COVID-19) neutralizing antibody (double-antigen sandwich) detection reagent obtained the CE1434 certificate. The strong recognition of the research and development technology of viral in vitro diagnostic reagents has far-reaching significance for the development of the international market and brand expansion. The novel coronavirus (COVID-19) neutralizing antibody (double-antigen sandwich) detection reagent independently developed by Anhui Deepblue Medical has obtained the CE1434 certificate, which can not only be freely sold in the 31 EU member states, but also bring more convenience to the global anti-epidemic. Check resources. The blessing of the CE1434 certificate also reflects the European market's recognition of the performance and user experience of DeepBlue Medical products, and it is also a high affirmation of the comprehensive strength of DeepBlue Medical. At present, most countries and regions in the world have gradually shifted from nucleic acid testing during the outbreak to neutralizing antibody testing to assess whether immunity is protected. The Deepblue Medical Novel Coronavirus (COVID-19) Neutralizing Antibody (Double Antigen Sandwich) Detection Reagent can simply, quickly and effectively reflect the presence and level of neutralizing antibodies after vaccination, and play a guiding role in the need for booster vaccination. In the future, Deepblue Medical will continue to adhere to the vision of "based on the health industry, give full play to the advantages of science and technology, and build a health industry aircraft carrier", strive to develop better products, and contribute to the global epidemic prevention and control and the evaluation of the immune effect of vaccines!
    View More
  • Hefei Mayor Ge Bin and staff from the Health and Health Commission visited and investigated DEEPBLUE Medical

    Company News Mar 21, 2022

    Hefei Mayor Ge Bin and staff from the Health and Health Commission visited and investigated DEEPBLUE Medical
    On the morning of March 13, 2022, Ge Bin, member of the Standing Committee of the Hefei Municipal Party Committee, Executive Deputy Mayor, and related colleagues from the Health and Health Commission visited Anhui DEEPBLUE Medical Technology Co., Ltd. (hereinafter referred to as "DeepBlue Medical") to investigate and investigate the DEEPBLUE New Coronavirus antigen test Reagent development status. Mr. Zhang Chao, chairman of DEEPBLUE Medical, Ms. Chen Fengling, general manager, and the heads of relevant departments warmly received and accompanied the visit and research. Vice Mayor Ge and his entourage came to DEEPBLUE Medical located in Mingzhu Industrial Park and visited the automation workshop of DEEPBLUE Medical. During the visit, Zhang Chao, Chairman of DEEPBLUE, explained in detail the research and development process, production process and production capacity of the New Coronavirus antigen detection reagent. Afterwards, Chairman Zhang Chao reported to Vice Mayor Ge on the development and production and operation of the New Coronavirus antigen detection reagent under the new situation of DEEPBLUE Medical, and introduced in detail the research and development of the new coronavirus antigen detection reagent and the overseas listing process, and the products in the market. Clinical performance testing of overseas authoritative testing institutions, overseas product registration and export sales. Mayor Ge and his entourage fully affirmed and praised the development of DEEPBLUE Medical, and said that since the evening of March 11, the comprehensive team of the State Council's joint prevention and control mechanism for New coronavirus pneumonia decided to add antigen testing as a supplement on the basis of nucleic acid testing. After organizing and formulating the "New Coronavirus Antigen Detection Application Plan (Trial)", Hefei City is studying and formulating policies to promote the development of medical devices and biopharmaceutical industries, further improving the ability to serve enterprises, continuously optimizing the business environment, and helping enterprises in a timely manner. Solve the problems encountered in the development and provide good services for the development of the enterprise. According to the investigation conducted by Vice Mayor Ge and his delegation, Chairman Zhang Chao said that DEEPBLUE Medical is currently actively promoting the application for the registration certificate of the New Coronavirus antigen test in China, and will continue to innovate and reform in the future, strive to develop and produce better products, and further help The prevention and control of the New Coronavirus epidemic in the province has contributed to the economic development of Hefei City.
    View More
  • Secretary Yu Aihua visited DEEPBLUE Medical for investigation and research

    Company News Mar 21, 2022

    Secretary Yu Aihua visited DEEPBLUE Medical for investigation and research
    On the afternoon of March 17, Yu Aihua, Member of the Standing Committee of the Provincial Party Committee and Secretary of the Municipal Party Committee, went to Hefei High-tech Zone to preach the spirit of the National Two Sessions, investigate the biopharmaceutical industry and grass-roots party building work, and coordinate on-site to help enterprises solve problems. Wu Lihua, director of the Provincial Drug Administration, and city leaders Shan Hu and Song Daojun attended the ceremony. Ms. Chen Fengling, general manager of DEEPBLUE Medical, and the heads of relevant departments warmly received and accompanied the visit and research.     Secretary Yu expressed strong interest in the New Coronavirus series testing products of different languages and specifications displayed by DEEPBUE Medical. Ms. Chen Fengling, general manager of DEEPBLUE Medical, introduced the self-developed New Coronavirus antigen detection reagents to Secretary Yu and his party by taking the product types and usage methods as the starting point. Secretary Yu fully affirmed and praised the development of DEEPBLUE Medical. After learning about the production and operation of DEEPBUE Medical in detail and experiencing the products on site, Secretary Yu Aihua attached great importance to discussing the trial of the New Coronavirus antigen product in Hefei with relevant departments on the spot, and requested the development and reform, Departments such as economics and information technology, science and technology and other departments will send personnel to station to help enterprises carry out registration application work. Ms. Chen Fengling, general manager of DEEPBLUE Medical, expressed her heartfelt thanks to the leaders of Secretary Yu and his party for their concern and support, and said that she would actively cooperate with relevant departments to complete the submission of application materials for the domestic listing registration certificate, promote the development of local medical and health services at a higher level, and serve the current severe epidemic situation. Contribute scientific research to the situation.
    View More
  • DEEPBLUE Medical Participates in Epidemic Prevention and Control

    Company News Mar 17, 2022

    DEEPBLUE Medical Participates in Epidemic Prevention and Control
    As a responsible and responsible enterprise, DEEPBLUE Medical has been actively repaying the society and continuously fulfilling its corporate citizenship responsibilities. DEEPBLUE Medical has been actively practicing corporate social responsibility for a long time, making continuous efforts in multiple dimensions, focusing on poverty alleviation, education, community, health and other directions, and integrating the core advantages and responsibilities of the enterprise into public welfare and charity. In the spring of 2020, a sudden epidemic disrupted people's lives and touched everyone's heart. Responsible enterprises and caring people from all walks of life have contributed to the prevention and control of the epidemic, and made concerted efforts with all the "guardians" who are fighting on the front line through various forms of donations to fight the epidemic. Bits of little love converge into a stream of warmth that warms people's hearts. In the fight against the epidemic, DEEPBLUE Medical continues to have caring tributaries to join in this "battle" to do their part to fight the epidemic. 1.Donate to Hong Kong On February 21, 2022, the Spring Festival was supposed to be full of flavor, but Hong Kong, China was shrouded in a severe pneumonia epidemic. Ms. Chen Fengling, general manager of DEEPBLUE Medical, actively fulfilled her social responsibilities, gathered strengths in the field to give full play to the industry's strengths, organized the company to donate 20 boxes of COVID-19 antigen front nose self-testing reagents to Hong Kong, and received them from the community in Hong Kong on March 10. Thank you letter from Anti-epidemic Connection. 2.Donate to King's College London In March 2020, DEEPBLUE Medical donated 10,000 SARS-CoV-2 (IgG/IgM) antibody detection kits to King's College London through Peking University HSBC Business School, and received a letter from Mr. Robert Lechler, Senior Vice President of King's College, UK. Thank you letter, the letter said: "One World, One Fight". DEEPBLUE Medical is proud to join hands with the United Kingdom to fight the epidemic, and is even more proud to receive a letter of thanks from Mr. Robert Lechler. 3.Donate to some schools in the province DEEPBLUE Medical donated hand sanitizer gel to Hefei High-tech Zone for use in school resumption. Donated hand sanitizer gel to the Feixi County Yandian Township Special Needs Support Center, Anhui Red Cross Fraternity School, Huangshan Jinchuan Middle School and Taihu Shahe Middle School for epidemic prevention and control. Deep Blue Medical cares about the elderly and children, and the elderly care center and school work together to fight the "epidemic". 4.Help Wuhan Epidemic Prevention and Control At the beginning of 2020, the new crown pneumonia epidemic broke out in Wuhan, Hubei Province for the first time. DEEPBLUE Medical responded quickly and started the donation process as soon as possible to make targeted donations to Wuhan Union Hospital in ...
    View More
  • DEEPBLUE Medical donated COVID-19 antigen detection kit to help Hefei fight the epidemic

    Company News Mar 19, 2022

    DEEPBLUE Medical donated COVID-19 antigen detection kit to help Hefei fight the epidemic
    At present, the situation of at home and abroad is still severe, and the number of new cases continues to rise, which has a serious impact on the lives and health of the people. In the face of the current epidemic prevention situation, DEEPBLUE Medical actively responded to the donation ceremony of COVID-19 antigen detection kit organized by the Hefei Municipal Government, donated 2 million copies of COVID-19 antigen detection kit to the Hefei Red Cross Society, and explained the responsibility of the enterprise with practical actions with responsibility. The donated products are tested by self-collected nasal tip swabs. The operation is simple, and the test results can be obtained in 15 minutes. It is effective for the detection of various mutant strains such as Delta and Omicron, and can be widely used in various types of viruses. Scenarios, such as airports, homes, schools, communities, etc., can alleviate the limitations caused by nucleic acid detection capabilities and can be used as a powerful supplement to nucleic acid detection. This time, DEEPBLUE Medical helped the county and district governments in Hefei City to prevent and control the epidemic by way of free donations, and no sales were carried out. For the convenience of citizens, the donated COVID-19 antigen detection kit are also printed in both Chinese and English. It is reported that in the next step, the Hefei Red Cross Society will distribute the batch of loving COVID-19 antigen detection kit reagents to all units, counties and districts as soon as possible in accordance with the unified arrangement of the Municipal Epidemic Prevention and Control Emergency Headquarters. Hefei citizens can pass the test on their own. This product performs home self-testing, which provides a strong guarantee for the rapid screening needs of large-scale people and helps Hefei fight the epidemic. Since the outbreak of COVID-19 antigen detection kit, DEEPBLUE Medical, as an in vitro diagnostic reagent manufacturer, has shouldered the social responsibility of anti-epidemic and epidemic prevention. At present, DEEPBLUE Medical provides self-developed COVID-19 series detection kits, which can meet different application scenarios of new crown virus rapid detection. DEEPBLUE Medical's Covid-19 antigen detection kits have been exported to 50 countries and regions around the world, and have been registered in more than 30 countries around the world, and the number of COVID-19 series product registration certificates has reached 95. DEEPBLUE Medical will continue to pay close attention to the needs of epidemic prevention and control, and fully support and effectively respond to the epidemic. I believe that with the joint support of all forces in the whole society, we will surely be able to win the battle against the epidemic.
    View More
  • DEEPBLUE Medical takes quick action to implement the donation commitment

    Company News Mar 20, 2022

    DEEPBLUE Medical takes quick action to implement the donation commitment
    The virus is ruthless, but there is love in the world. At present, in the tense battle of the whole people to fight against the COVID-19 epidemic, DEEPBLUE Medical donated the COVID-19 antigen detection kits, practiced its social responsibility with practical actions, reflected its mission, and helped the epidemic prevention and control work. In order to support Hefei's epidemic prevention and control work, on March 15th and 16th, DEEPBLUE Medical donated  COVID-19 antigen detection kits to the High-tech Zone Emergency Office and Luyang District Emergency Office respectively. The Municipal Red Cross Society donated 2 million copies of the COVID-19 antigen detection kits, explaining the responsibility and responsibility of enterprises with practical actions. In the current epidemic situation, fast words take the lead. In order to send the donated materials to various regions in Hefei as quickly as possible, DEEPBLUE Medical makes it play a role in the prevention and control of the epidemic. As soon as the donation ceremony is over, the deployment of donation matters will be started immediately. Efficiently complete the inventory and docking of donated products, so that each box of the COVID-19 antigen detection kits can exert the greatest value. On the evening of March 19, the staff of the Red Cross Society of Hefei came to the DEEPBLUE Medical Storage Center in Mingzhu Industrial Park to connect the distribution and transportation of reagents on site. The first batch of 430,000 the COVID-19 antigen detection kits were successively sent to Chaohu City, Lujiang County, Yaohai District, Baohe District, Shushan District and Luyang District. At 22 o'clock, the last anti-epidemic material transport vehicle left, and the friends of DEEPBLUE Medical temporarily relaxed their highly tense nerves. In the critical period of epidemic prevention and control, boxes of the COVID-19 antigen detection kits interpret the corporate responsibility and love of DEEPBLUE Medical. DEEPBLUE Medical uses practical actions to transmit positive social energy, and Hefei is more determined to win the epidemic. The battle of prevention and control has injected strong spiritual strength, fighting against the epidemic with everyone and protecting health and tranquility. In this battlefield without gunpowder smoke, DEEPBLUE Medical believes that by working together and united, we will be able to win the battle of epidemic prevention and control as soon as possible!
    View More
  • The second batch of anti-epidemic materials donated by DEEPBLUE Medical has been arranged

    Company News Mar 24, 2022

    The second batch of anti-epidemic materials donated by DEEPBLUE Medical has been arranged
    On March 22, due to the strong wind and rain, the temperature dropped significantly. After receiving the notice of medical supplies distribution from the Hefei Red Cross Society, the teams from DEEPBLUE Medical expedited packing and labeling the materials at each material demand point. , transport. They braved the wind and rain, and told an extraordinary story in an ordinary position with practical actions...... On the road downstairs in the factory area, the wind and rain can't stop the steps of the DEEPBLUE Medical partners' contribution of love. They are loading trucks in the rain. Everyone dare not stop to ensure that the medical supplies will be delivered in the fastest and shortest time. Shipping is in place. The material transport vehicles are loaded with the COVID-19 antigen detection kits that will be shipped to Hefei counties and districts. These vehicles full of love and warmth will arrive in designated areas around the early morning of March 23. Although it was late at night, the dark blue friends were still busy. In order to prevent the rain on the bottom of the truck from soaking the materials, some quickly found thicker cardboard and spread it on the truck; some quickly put boxes of the COVID-19 antigen detection kits. Packed and transported on pallets; some neatly transported and stacked the donated materials on the pallets in boxes... After loading, the trucks full of materials were covered with rain cloths, bundled and reinforced, arranged in order, and quickly drove to the designated area. 
    View More
1 2 3

A total of 3 pages

SEND A MESSAGE
If you have questions or suggestions,please leave us a message,we will reply you as soon as we can!
top
Leave A Message
Leave A Message
If you have questions or suggestions,please leave us a message,we will reply you as soon as we can!

Home

Product